One Zyme
PrivateLast Round
VC Round
Jan 1, 2025
Company Overview
One Zyme is a biotechnology company that provides an AI-powered intelligence platform for pharmaceutical business development, competitive intelligence, and R&D strategy.
Sector
Healthcare & Life Sciences
Verticals
Business Intelligence, Biotechnology, Healthcare Analytics, Workflow Automation, Drug Discovery
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
One Zyme Comparables
Compare One Zyme with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Maven Bio | 94% | |
| Prudentia Sciences | 89% | |
| Floatz | 88% |
One Zyme Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jan 1, 2025 |
Key People
Founding team and executive leadership
One Zyme Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Service Provider Capital | VC Round |
| Invariantes Fund | VC Round |
| Esplanade Ventures | VC Round |
| Newfund Capital | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 3, 2026
Monthly visitors increased 41% MoM.
- Jan 1, 2025
Fundraise included Esplanade Ventures, Invariantes Fund, Newfund Capital, and Service Provider Capital.
One Zyme Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about One Zyme's valuation, stock price, and market status.
Is One Zyme a public or private company?
One Zyme is a private company.
What is the current stock price of One Zyme?
One Zyme is a private company with no public stock price. No recent secondary market data is available.
How much is One Zyme worth (valuation)?
Valuation information for One Zyme is not publicly available.
Can I buy One Zyme stock?
One Zyme shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was One Zyme's last funding round?
One Zyme's most recent funding round was VC Round on January 1, 2025.
Who are the main investors in One Zyme?
Key investors in One Zyme include Service Provider Capital, Invariantes Fund, Esplanade Ventures, Newfund Capital.
Will One Zyme IPO soon?
No public IPO plans have been announced for One Zyme.
How can I track One Zyme secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor One Zyme's secondary market activity and sign up for updates.